LXRX: Lexicon Pharmaceuticals, Inc. Stock

by  •  • Comments Off on LXRX: Lexicon Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 184.29
Enterprise Value ($M) 46.63
Book Value ($M) 145.95
Book Value / Share 0.40
Price / Book 1.26
NCAV ($M) 85.49
NCAV / Share 0.24
Price / NCAV 2.16

Profitability (mra)
Return on Invested Capital (ROIC) -0.80
Return on Assets (ROA) -0.48
Return on Equity (ROE) -0.69

Liquidity (mrq)
Quick Ratio 5.25
Current Ratio 5.26

Balance Sheet (mrq) ($M)
Current Assets 237.96
Assets 298.42
Liabilities 152.47
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 31.08
Operating Income -197.12
Net Income -200.40
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -178.78
Cash from Investing -15.38
Cash from Financing 238.35

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
12-09 13D/A Invus, L.P. 37.70 0.00
11-14 13G/A Biotechnology Value Fund L P 0.00 -100.00
11-12 13G/A Fmr Llc 13.79 28.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-07 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 or ☐ TRANSITION REPORT PUR
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 586,592 2,424,360 24.20
2025-04-16 1,922,848 4,564,031 42.13
2025-04-15 1,746,323 4,547,686 38.40
2025-04-14 2,861,913 7,352,358 38.93

(click for more detail)

Similar Companies
KURA – Kura Oncology, Inc. KYTX – Kyverna Therapeutics, Inc.
LVTX – LAVA Therapeutics N.V. LYEL – Lyell Immunopharma, Inc.
MCRB – Seres Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io